SG11201704085QA - Heparan sulphates for use in repair and/or regeneration of skin - Google Patents

Heparan sulphates for use in repair and/or regeneration of skin

Info

Publication number
SG11201704085QA
SG11201704085QA SG11201704085QA SG11201704085QA SG11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA SG 11201704085Q A SG11201704085Q A SG 11201704085QA
Authority
SG
Singapore
Prior art keywords
regeneration
repair
skin
heparan sulphates
heparan
Prior art date
Application number
SG11201704085QA
Other languages
English (en)
Inventor
Simon Cool
Victor Nurcombe
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG11201704085QA publication Critical patent/SG11201704085QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11201704085QA 2014-11-19 2015-11-19 Heparan sulphates for use in repair and/or regeneration of skin SG11201704085QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201408007P 2014-11-19
PCT/SG2015/050464 WO2016080916A1 (en) 2014-11-19 2015-11-19 Heparan sulphates for use in repair and/or regeneration of skin

Publications (1)

Publication Number Publication Date
SG11201704085QA true SG11201704085QA (en) 2017-06-29

Family

ID=56014304

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201704085QA SG11201704085QA (en) 2014-11-19 2015-11-19 Heparan sulphates for use in repair and/or regeneration of skin

Country Status (6)

Country Link
US (1) US10471091B2 (enrdf_load_stackoverflow)
EP (1) EP3220922B1 (enrdf_load_stackoverflow)
JP (1) JP6709217B2 (enrdf_load_stackoverflow)
CN (1) CN107249599A (enrdf_load_stackoverflow)
SG (1) SG11201704085QA (enrdf_load_stackoverflow)
WO (1) WO2016080916A1 (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015015814A (es) 2013-05-16 2016-06-02 Agency Science Tech & Res Sulfatos de heparán.
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate
CA2998170C (en) 2015-09-15 2023-10-03 Savage Medical, Inc. Devices and methods for anchoring a sheath in a tissue cavity
US10905843B2 (en) 2016-01-18 2021-02-02 Fisher & Paykel Healthcare Limited Humidification of respiratory gases
JP6815782B2 (ja) * 2016-07-29 2021-01-20 小林製薬株式会社 α−ＳＭＡ産生抑制剤
CN106544318A (zh) * 2016-11-28 2017-03-29 广东万海细胞生物科技有限公司 促进脐带间充质干细胞定向分化为脂肪细胞的方法
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
JPWO2024080183A1 (enrdf_load_stackoverflow) * 2022-10-14 2024-04-18

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019087A (en) 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
JPH0240399A (ja) 1988-07-27 1990-02-09 Takeda Chem Ind Ltd 線維芽細胞増殖因子ムテインの複合体あるいは組成物
GB9017008D0 (en) 1990-08-02 1990-09-19 Erba Carlo Spa Process for the enzymatic preparation of basic fibroblast growth factor
MX9201801A (es) 1991-04-16 1992-10-30 Seikagaku Kogyo Co Ltd Oligosacarido que tiene afinidad para el factor de desarrollo del fibroplasto y procedimiento para producirlo.
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
JP4768936B2 (ja) * 2000-08-07 2011-09-07 生化学工業株式会社 硫酸基を有するオリゴ糖
FR2812551B1 (fr) * 2000-08-07 2003-03-28 Virsol Forme pharmaceutique comprenant un materiau support a base de methylidene malonate et un facteur de regulation cellulaire
US20060183712A1 (en) 2005-02-17 2006-08-17 The Texas A&M University System Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor
WO2010011185A1 (en) 2008-07-21 2010-01-28 Agency For Science, Technology And Research Stem cells obtained through in vitro culture with heparan sulfate
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
US9498494B2 (en) * 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
GB2463474B (en) 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
ES2507495T3 (es) 2008-11-20 2014-10-15 Laboratori Derivati Organici S.P.A. Uso de sulfato de heparano en preparaciones cosmetológicas y dermatológicas
FR2940610B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
US20130071443A1 (en) * 2011-09-16 2013-03-21 Agency For Science, Technology And Research Glycosaminoglycans
MX2015015814A (es) * 2013-05-16 2016-06-02 Agency Science Tech & Res Sulfatos de heparán.
US10493012B2 (en) 2014-11-19 2019-12-03 Agency For Science, Technology And Research Cosmetic use of heparan sulphate

Also Published As

Publication number Publication date
US10471091B2 (en) 2019-11-12
EP3220922A4 (en) 2018-07-11
CN107249599A (zh) 2017-10-13
EP3220922A1 (en) 2017-09-27
JP2017536454A (ja) 2017-12-07
JP6709217B2 (ja) 2020-06-10
US20170319615A1 (en) 2017-11-09
EP3220922B1 (en) 2020-10-14
WO2016080916A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
IL255116A0 (en) Methods for tissue repair and regeneration
IL258725A (en) Polypeptides with an extracellular cd80 site and their use in cancer therapy
HUE045754T2 (hu) Blautia stercosis és wexlerae gyulladásos és autoimmun betegségek kezelésében történõ alkalmazásra
HUE047914T2 (hu) Bõr tisztítására és kezelésére szolgáló eszköz és eljárás
SG11201704085QA (en) Heparan sulphates for use in repair and/or regeneration of skin
IL285104A (en) Device and method for tissue repair
ZA201704726B (en) Peptides and their use in the treatment of skin
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
PL2910980T3 (pl) Sposób i układ do badania ciała ludzkiego z wykorzystaniem rozpraszania wstecznego
PL3160464T3 (pl) 6-hydroksybuspiron do stosowania w leczeniu zaburzeń ruchowych
SMT202200151T1 (it) Composizioni e metodi per l’uso nel trattamento di omocistinuria.
IL246855A0 (en) Materials for use in the treatment of retinitis
SG11201609026UA (en) Heparan sulphates
PL3194968T3 (pl) Wykrywanie i traktowanie bydlęcego wirusa opryszczki
SG11201704086WA (en) Cosmetic use of heparan sulphate
DK3145548T3 (en) Aqueous gel composition and its use
GB201423270D0 (en) The combination for soothing and repair of the skin
IL255012A0 (en) Preparations and methods for treating skin conditions
PL3262069T3 (pl) Zastosowanie przeciwciał i antagonistów skierowanych przeciwko LRG1 w leczeniu
GB201508931D0 (en) Materials and methods for tissue regeneration
GB201513964D0 (en) Improvements in or relating to emergency apparatus and/or methods
SG11201701618SA (en) Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders
IL250244B (en) Prevention and treatment of inflammatory skin diseases
TH1601000569A (th) วิธีการสำหรับซ่อมแซมเส้นผมและผิวหนัง
ZA201408464B (en) Composition for the use in treatment of asthma